Cantor Fitzgerald Has Lowered Expectations for Core Scientific (NASDAQ:CORZ) Stock Price

Core Scientific (NASDAQ:CORZ) had its price objective dropped by stock analysts at Cantor Fitzgerald from $26.00 to $25.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 55.18% from the stock’s previous close.

Several other equities research analysts have also commented on the stock. Keefe, Bruyette & Woods upped their price target on shares of Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a research report on Tuesday, January 27th. Citizens Jmp upgraded shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 target price for the company in a research report on Thursday, December 18th. BTIG Research upgraded shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Tuesday, January 6th. HC Wainwright reiterated a “buy” rating and set a $25.00 price target on shares of Core Scientific in a research note on Tuesday. Finally, Sanford C. Bernstein boosted their price objective on shares of Core Scientific from $17.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Core Scientific presently has an average rating of “Moderate Buy” and a consensus target price of $24.41.

Core Scientific Trading Down 2.3%

CORZ traded down $0.38 during trading on Tuesday, hitting $16.11. 4,629,450 shares of the company’s stock traded hands, compared to its average volume of 10,875,620. The stock has a market capitalization of $5.00 billion, a price-to-earnings ratio of 106.07 and a beta of 6.86. The company’s 50 day simple moving average is $17.28 and its two-hundred day simple moving average is $16.96. Core Scientific has a 12-month low of $6.20 and a 12-month high of $23.63.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings results on Monday, March 2nd. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.69. The company had revenue of $79.76 million during the quarter, compared to the consensus estimate of $118.45 million. During the same quarter in the prior year, the firm earned ($0.69) earnings per share. The business’s revenue was down 16.0% compared to the same quarter last year. On average, equities analysts expect that Core Scientific will post 0.52 EPS for the current year.

Hedge Funds Weigh In On Core Scientific

Several large investors have recently made changes to their positions in the business. Allworth Financial LP grew its position in shares of Core Scientific by 206.5% during the third quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after purchasing an additional 950 shares in the last quarter. Larson Financial Group LLC boosted its stake in Core Scientific by 936.7% in the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after purchasing an additional 1,686 shares during the period. HHM Wealth Advisors LLC grew its holdings in Core Scientific by 96.5% during the 2nd quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock valued at $33,000 after buying an additional 946 shares in the last quarter. Osaic Holdings Inc. lifted its holdings in shares of Core Scientific by 112.1% in the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock worth $34,000 after buying an additional 1,066 shares in the last quarter. Finally, Danske Bank A S bought a new position in shares of Core Scientific during the fourth quarter worth $36,000.

Core Scientific News Roundup

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Colocation revenue surged 268% year-over-year, signaling strong demand for Core Scientific’s high-density hosting business and improved unit economics for its digital infrastructure operations. Core Scientific Colocation Revenue Surges 268% Amid Mixed Q4 Results
• Positive Sentiment: Company-released results and slides show an earnings beat (reported EPS of $0.42 versus consensus of -$0.27) and management emphasized operational progress and RFS (ready-for-service) milestones. Those beats support the view that profitability can improve as colocation scales. Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results
• Neutral Sentiment: Management reiterated a 1.5 GW leasable pipeline (multi-geography builds) as a growth plan — a meaningful long-term positive for capacity and revenue but one that requires capital and execution. Investors are parsing timing and funding. Press Release / Expansion comment
• Neutral Sentiment: The earnings call transcript provides additional color on operations, margin drivers, and RFS timing for facility builds — useful for assessing cadence but not changing the mixed headline. Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous/zeroed-out and is not providing meaningful near-term signal for share pressure. (Treat as noise until validated.)
• Negative Sentiment: Revenue missed expectations materially: reported revenue was ~$79.8M versus analyst estimates near $118.5M, and sales were down ~16% year-over-year — a reminder that top-line recovery lags the profitability signal. Zacks: Key Metrics Versus Estimates
• Negative Sentiment: Some outlets reported Q4 results differently (one flagged a loss), contributing to market confusion and volatility. This inconsistency, combined with the revenue miss, pressured shares. Zacks: Reports Q4 Loss, Misses Revenue Estimates
• Negative Sentiment: Market reaction included an intraday share drop (~2.8% reported by some outlets) as investors weighed expansion risks, revenue shortfall, and the need for capital to scale the 1.5 GW pipeline. Blockonomi: Shares Drop as Company Pushes Forward with 1.5GW Expansion

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.